Catheter Precision Shares Scheduled to Reverse Split on Monday, October 5th (NYSEAMERICAN:VTAK)

Shares of Catheter Precision, Inc. (NYSEAMERICAN:VTAK) are set to reverse split on Monday, October 5th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 4th.

Catheter Precision Stock Up 4.9%

Shares of NYSEAMERICAN:VTAK opened at $0.15 on Thursday. The firm has a market cap of $2.16 million, a P/E ratio of -0.02 and a beta of -1.03. Catheter Precision has a 12-month low of $0.13 and a 12-month high of $3.20. The business has a fifty day simple moving average of $0.22 and a 200 day simple moving average of $0.69. The company has a quick ratio of 0.18, a current ratio of 0.19 and a debt-to-equity ratio of 0.19.

Catheter Precision (NYSEAMERICAN:VTAK) last announced its earnings results on Friday, August 14th. The company reported ($0.92) EPS for the quarter, topping the consensus estimate of ($19.00) by $18.08. The firm had revenue of $1.02 million for the quarter, compared to the consensus estimate of $2.00 million. Catheter Precision had a negative return on equity of 37.53% and a negative net margin of 656.03%.

Catheter Precision Company Profile

Catheter Precision, Inc is a medical device company focused on developing technologies for electrophysiology procedures used to diagnose and treat cardiac arrhythmias. Its products are designed to support physicians during catheter-based cardiac procedures, particularly those involving ventricular arrhythmias.

The company’s portfolio includes the VIVO system, a noninvasive cardiac mapping platform intended to help physicians identify the origin of ventricular arrhythmias and plan catheter ablation procedures.